Notably, CDKN2A promoter hypermethylation has also been associated with the TCGA CIMP tumors and this was true for this cohort of HLRCC tumors but showed no correlation with reduced mRNA expression (S4 Fig in S1 File). Here, CDKN2A is linked to hereditary leiomyomatosis and renal cell cancer.